While the exact causes of long COVID are not fully understood, ongoing research aims to better understand the underlying mechanisms and to develop effective treatments for those experiencing prolonged symptoms after a COVID-19 infection.
In this live discussion, physician-scientist and long COVID researcher Ziyad Al-Aly, MD, will examine new developments in long COVID research and share insights from his own findings. Join us!
Featuring:
- Jeremy Faust, MD, (moderator) editor-in-chief at MedPage Today ()
- Ziyad Al-Aly, MD, chief of research and development at the VA St. Louis Health Care System, and clinical epidemiologist at Washington University in St. Louis ()
How do I join? on Instagram!
When is the event? Tune in Wednesday, January 17 at 1 p.m. ET
Can I submit questions? Yes, we encourage questions! Submit your questions prior to the event by commenting below.
Related articles:
'Long Flu' Is Real -- But Long COVID Is Worse, Study Shows
Long COVID Blood Tests Show Distinct Immune and Hormone Function
Cognitive Dysfunction, Viral Persistence Studied First in New Long COVID Trials
Paxlovid May Lower Long COVID Risk, VA Study Suggests
Brain Structure, Widespread Connectivity Changes Seen With Long COVID
Long COVID Neurologic Symptoms Vary Based on Severity of Initial Infection
Many Long COVID Outcomes Resolve in a Year, Analysis Suggests
Long-Term Neurologic Problems Rise by 7% After SARS-CoV-2 Infection
Lower Long COVID Risk Tied to More Vaccine Doses
Long COVID Can Take a Toll on the Vaccinated, Too
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/GBooth_188.jpg)